Goldman Sachs’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$146M Buy
666,328
+62,595
+10% +$13.7M 0.02% 593
2025
Q1
$135M Buy
603,733
+91,707
+18% +$20.5M 0.02% 573
2024
Q4
$168M Buy
512,026
+96,408
+23% +$31.6M 0.03% 479
2024
Q3
$125M Sell
415,618
-57,995
-12% -$17.4M 0.02% 602
2024
Q2
$156M Buy
473,613
+11,305
+2% +$3.72M 0.03% 520
2024
Q1
$183M Buy
462,308
+28,119
+6% +$11.1M 0.03% 461
2023
Q4
$153M Sell
434,189
-40,107
-8% -$14.1M 0.03% 508
2023
Q3
$178M Sell
474,296
-50,912
-10% -$19.1M 0.04% 414
2023
Q2
$201M Buy
525,208
+21,171
+4% +$8.1M 0.04% 373
2023
Q1
$175M Buy
504,037
+70,587
+16% +$24.5M 0.04% 410
2022
Q4
$102M Buy
433,450
+49,602
+13% +$11.7M 0.03% 606
2022
Q3
$94.5M Sell
383,848
-40,101
-9% -$9.87M 0.02% 628
2022
Q2
$128M Sell
423,949
-134,796
-24% -$40.8M 0.03% 503
2022
Q1
$229M Buy
558,745
+53,044
+10% +$21.8M 0.05% 339
2021
Q4
$237M Buy
505,701
+13,909
+3% +$6.52M 0.05% 341
2021
Q3
$209M Sell
491,792
-321,172
-40% -$136M 0.04% 360
2021
Q2
$292M Sell
812,964
-324,378
-29% -$116M 0.07% 245
2021
Q1
$320M Sell
1,137,342
-113,530
-9% -$32M 0.08% 196
2020
Q4
$354M Sell
1,250,872
-84,904
-6% -$24.1M 0.09% 172
2020
Q3
$367M Buy
1,335,776
+432,092
+48% +$119M 0.1% 140
2020
Q2
$205M Buy
903,684
+41,013
+5% +$9.32M 0.06% 273
2020
Q1
$131M Sell
862,671
-43,185
-5% -$6.57M 0.05% 374
2019
Q4
$136M Sell
905,856
-86,939
-9% -$13.1M 0.03% 500
2019
Q3
$141M Buy
992,795
+63,410
+7% +$8.99M 0.04% 445
2019
Q2
$116M Sell
929,385
-148,773
-14% -$18.6M 0.03% 541
2019
Q1
$119M Buy
1,078,158
+155,115
+17% +$17.1M 0.04% 523
2018
Q4
$90.5M Sell
923,043
-50,073
-5% -$4.91M 0.03% 605
2018
Q3
$120M Buy
973,116
+162,252
+20% +$20M 0.03% 591
2018
Q2
$80.5M Buy
810,864
+143,818
+22% +$14.3M 0.02% 813
2018
Q1
$58.9M Sell
667,046
-110,223
-14% -$9.73M 0.02% 973
2017
Q4
$76.7M Sell
777,269
-204,354
-21% -$20.2M 0.02% 839
2017
Q3
$94.5M Buy
981,623
+45,938
+5% +$4.42M 0.02% 722
2017
Q2
$88.4M Buy
935,685
+86,022
+10% +$8.13M 0.02% 727
2017
Q1
$69.3M Sell
849,663
-76,145
-8% -$6.21M 0.02% 844
2016
Q4
$78.5M Buy
925,808
+15
+0% +$1.27K 0.02% 746
2016
Q3
$69M Buy
925,793
+242,215
+35% +$18M 0.02% 801
2016
Q2
$51.9M Buy
683,578
+57,564
+9% +$4.37M 0.02% 891
2016
Q1
$43.4M Buy
626,014
+342,331
+121% +$23.7M 0.01% 981
2015
Q4
$17.1M Buy
283,683
+85,604
+43% +$5.15M 0.01% 1414
2015
Q3
$10.7M Buy
198,079
+68,879
+53% +$3.73M ﹤0.01% 1609
2015
Q2
$7.5M Sell
129,200
-8,532
-6% -$496K ﹤0.01% 1840
2015
Q1
$8.29M Buy
137,732
+101,561
+281% +$6.11M ﹤0.01% 1768
2014
Q4
$1.93M Sell
36,171
-13,763
-28% -$733K ﹤0.01% 2530
2014
Q3
$2.24M Sell
49,934
-9,993
-17% -$447K ﹤0.01% 2454
2014
Q2
$2.53M Buy
59,927
+11,657
+24% +$492K ﹤0.01% 2404
2014
Q1
$2.13M Sell
48,270
-135,573
-74% -$5.97M ﹤0.01% 2516
2013
Q4
$9.02M Buy
183,843
+40,966
+29% +$2.01M ﹤0.01% 1620
2013
Q3
$5.88M Buy
142,877
+34,421
+32% +$1.42M ﹤0.01% 1794
2013
Q2
$3.81M Buy
+108,456
New +$3.81M ﹤0.01% 1931